Kcm Investment Advisors LLC Abbott Laboratories Transaction History

Kcm Investment Advisors LLC

  • $2.91 Billion
  • Q3 2024

A detailed history of Kcm Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kcm Investment Advisors LLC holds 144,381 shares of ABT stock, worth $16.5 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
144,381
Previous 146,309 1.32%
Holding current value
$16.5 Million
Previous $15.2 Million 8.28%
% of portfolio
0.57%
Previous 0.55%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$100.07 - $118.13 $192,934 - $227,754
-1,928 Reduced 1.32%
144,381 $16.5 Million
Q2 2024

Jul 29, 2024
SELL
$100.73 - $112.44 $20,851 - $23,275
-207 Reduced 0.14%
146,309 $15.2 Million
Q1 2024

May 07, 2024
SELL
$109.52 - $120.96 $125,728 - $138,862
-1,148 Reduced 0.78%
146,516 $16.7 Million
Q4 2023

Feb 13, 2024
SELL
$90.19 - $110.4 $543,935 - $665,822
-6,031 Reduced 3.92%
147,664 $16.3 Million
Q3 2023

Nov 08, 2023
SELL
$95.53 - $114.62 $578,052 - $693,565
-6,051 Reduced 3.79%
153,695 $14.9 Million
Q2 2023

Aug 09, 2023
SELL
$100.78 - $112.29 $272,509 - $303,632
-2,704 Reduced 1.66%
159,746 $17.4 Million
Q1 2023

May 09, 2023
SELL
$96.86 - $114.01 $670,464 - $789,177
-6,922 Reduced 4.09%
162,450 $16.4 Million
Q4 2022

Jan 31, 2023
BUY
$95.06 - $111.52 $21,008 - $24,645
221 Added 0.13%
169,372 $18.6 Million
Q3 2022

Nov 10, 2022
SELL
$96.76 - $112.03 $2.88 Million - $3.34 Million
-29,811 Reduced 14.98%
169,151 $16.4 Million
Q2 2022

Aug 15, 2022
SELL
$102.07 - $123.37 $335,402 - $405,393
-3,286 Reduced 1.62%
198,962 $21.6 Million
Q1 2022

May 13, 2022
BUY
$114.02 - $139.04 $645,581 - $787,244
5,662 Added 2.88%
202,248 $23.9 Million
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $953,931 - $1.17 Million
8,257 Added 4.38%
196,586 $27.7 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $111,526 - $123,381
956 Added 0.51%
188,329 $22.2 Million
Q2 2021

Oct 21, 2021
BUY
$105.79 - $124.53 $12,694 - $14,943
120 Added 0.06%
187,373 $21.7 Million
Q2 2021

Aug 12, 2021
BUY
$105.79 - $124.53 $224,169 - $263,879
2,119 Added 1.14%
187,253 $21.7 Million
Q1 2021

May 13, 2021
BUY
$108.84 - $128.23 $458,107 - $539,720
4,209 Added 2.33%
185,134 $22.2 Million
Q4 2020

Feb 19, 2021
BUY
$105.0 - $114.42 $111,720 - $121,742
1,064 Added 0.59%
180,925 $19.8 Million
Q3 2020

Nov 16, 2020
SELL
$91.64 - $111.29 $1.03 Million - $1.26 Million
-11,290 Reduced 5.91%
179,861 $19.6 Million
Q2 2020

Aug 14, 2020
SELL
$76.57 - $98.0 $12,634 - $16,170
-165 Reduced 0.09%
191,151 $17.5 Million
Q1 2020

Apr 27, 2020
SELL
$62.82 - $91.86 $149,762 - $218,994
-2,384 Reduced 1.23%
191,316 $15.1 Million
Q4 2019

Feb 18, 2020
SELL
$78.51 - $87.4 $12,169 - $13,547
-155 Reduced 0.08%
193,700 $16.8 Million
Q3 2019

Nov 15, 2019
SELL
$81.84 - $88.74 $72,182 - $78,268
-882 Reduced 0.45%
193,855 $16.2 Million
Q2 2019

Aug 14, 2019
BUY
$72.88 - $85.0 $160,481 - $187,170
2,202 Added 1.14%
194,737 $16.4 Million
Q1 2019

May 16, 2019
BUY
$66.22 - $80.06 $147,140 - $177,893
2,222 Added 1.17%
192,535 $15.4 Million
Q4 2018

Feb 12, 2019
SELL
$65.56 - $74.27 $219,953 - $249,175
-3,355 Reduced 1.73%
190,313 $13.8 Million
Q3 2018

Nov 07, 2018
BUY
$60.81 - $73.36 $18,303 - $22,081
301 Added 0.16%
193,668 $0
Q2 2018

Aug 10, 2018
SELL
$57.57 - $63.54 $599,476 - $661,642
-10,413 Reduced 5.11%
193,367 $11.8 Million
Q1 2018

May 09, 2018
SELL
$56.27 - $63.62 $217,821 - $246,273
-3,871 Reduced 1.86%
203,780 $12.2 Million
Q4 2017

Feb 22, 2018
SELL
$53.68 - $57.47 $154,598 - $165,513
-2,880 Reduced 1.37%
207,651 $11.9 Million
Q3 2017

Nov 13, 2017
BUY
$48.06 - $53.64 $10.1 Million - $11.3 Million
210,531
210,531 $11.2 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Kcm Investment Advisors LLC Portfolio

Follow Kcm Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email